Phase III Study of CG100649 in Osteoarthritis Patients

NCT01765296 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

362

Enrollment

INDUSTRY

Sponsor class

Conditions

Localized Primary Osteoarthritis of Hip
Localized Primary Osteoarthritis of Knee

Interventions

DRUG: CG100649
DRUG: Celecoxib
DRUG: Placebo

Sponsor

CrystalGenomics, Inc.